Literature DB >> 19434382

[Autoinflammatory syndromes].

P Lamprecht1, W L Gross.   

Abstract

In its strict sense, the term "autoinflammatory syndromes" comprises the hereditary periodic fever syndromes (HPF), which are caused by mutations of pattern-recognition receptors (PRR) and perturbations of the cytokine balance. These include the crypyrinopathies, familial Mediterranean fever, TNF-receptor associated periodic fever syndrome (TRAPS), hyper-IgD and periodic syndrome (HIDS), pyogenic sterile arthritis, pyoderma gangrenosum and acne (PAPA) syndrome, NALP12-HPF, and the Blau syndrome. The diseases are characterized by spontaneous activation of cells of the innate immunity in the absence of ligands. Autoantibodies are usually not found. HPF clinically present with recurrent fever episodes and inflammation, especially of serosal and synovial interfaces and the skin. Intriguingly, PRR-mediated autoinflammtory mechanisms also play a role in a number of chronic inflammatory and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19434382     DOI: 10.1007/s00108-009-2302-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  30 in total

1.  Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

Authors:  M F McDermott; I Aksentijevich; J Galon; E M McDermott; B W Ogunkolade; M Centola; E Mansfield; M Gadina; L Karenko; T Pettersson; J McCarthy; D M Frucht; M Aringer; Y Torosyan; A M Teppo; M Wilson; H M Karaarslan; Y Wan; I Todd; G Wood; R Schlimgen; T R Kumarajeewa; S M Cooper; J P Vella; C I Amos; J Mulley; K A Quane; M G Molloy; A Ranki; R J Powell; G A Hitman; J J O'Shea; D L Kastner
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

Review 2.  Hereditary periodic fever.

Authors:  J P Drenth; J W van der Meer
Journal:  N Engl J Med       Date:  2001-12-13       Impact factor: 91.245

3.  Infliximab therapy in a patient with familial Mediterranean fever and chronic hip arthritis.

Authors:  Serdar Daysal; Gulhan Akcil; Berna Goker; Seminur Haznedaroglu; Nil Ercan; Mehmet Akif Ozturk
Journal:  Arthritis Rheum       Date:  2005-02-15

4.  Expansion of CD28-CD27-NKG2D+ effector memory T cells and predominant Th1-type response during febrile attacks in tumor necrosis factor-associated periodic syndrome.

Authors:  Julia U Holle; Dorin Capraru; Elena Csernok; Wolfgang L Gross; Peter Lamprecht
Journal:  Isr Med Assoc J       Date:  2006-02       Impact factor: 0.892

5.  Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever.

Authors:  Y Shinar; A Livneh; P Langevitz; N Zaks; I Aksentijevich; D E Koziol; D L Kastner; M Pras; E Pras
Journal:  J Rheumatol       Date:  2000-07       Impact factor: 4.666

6.  Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

Authors: 
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial.

Authors:  M Tunca; S Akar; M Soytürk; G Kirkali; H Resmi; H Akhunlar; O Gönen; J R Gallimore; P N Hawkins; E Tankurt
Journal:  Clin Exp Rheumatol       Date:  2004 Jul-Aug       Impact factor: 4.473

Review 8.  Cryopyrinopathies: update on pathogenesis and treatment.

Authors:  Bénédicte Neven; Anne-Marie Prieur; Pierre Quartier dit Maire
Journal:  Nat Clin Pract Rheumatol       Date:  2008-07-29

9.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

Authors:  Hal M Hoffman; Martin L Throne; N J Amar; Mohamed Sebai; Alan J Kivitz; Arthur Kavanaugh; Steven P Weinstein; Pavel Belomestnov; George D Yancopoulos; Neil Stahl; Scott J Mellis
Journal:  Arthritis Rheum       Date:  2008-08

10.  Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders.

Authors:  Leigh D Church; Michael F McDermott
Journal:  Curr Opin Mol Ther       Date:  2009-02
View more
  3 in total

1.  Comorbidities of hidradenitis suppurativa (acne inversa).

Authors:  Sabine Fimmel; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2010-01

2.  [Adult-onset Still's disease, Schnitzler syndrome, and autoinflammatory syndromes in adulthood].

Authors:  P Lamprecht
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 3.  Pyoderma gangrenosum: pathogenetic oriented treatment approaches.

Authors:  Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2014-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.